Code: 0710-2146
Seraseq® ctDNA MRD Panel Mix. ctDNA reference material for minimal residual disease monitoring NGS assay development and validation.
Price on Application
The Seraseq® ctDNA MRD Panel Mix is a circulating tumour DNA (ctDNA) reference material for Minimal Residual Disease (MRD) monitoring assay development and validation. Ultra-sensitive ctDNA-based MRD detection is increasingly used to monitor treatment response and detect early relapse in haematological and solid tumour malignancies.
Key features:
- ctDNA format optimised for ultra-sensitive MRD detection assay validation
- Supports development of tumour-informed and tumour-agnostic MRD panels
- Low allele frequency targets for limit-of-detection characterisation
- Compatible with NGS-based MRD monitoring workflows